Aromatic Beta-Blocker Atenolol

Atenolol is a synthetic aromatic beta-blocker drug used primarily for treating hypertension and angina. It falls under HTS 2942.00.05.00 as an aromatic organic compound classified as a drug, distinct from standard pharmaceuticals in Chapters 29 or 30. This code applies to specific aromatic or modified aromatic drugs not covered elsewhere.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
๐Ÿ‡จ๐Ÿ‡ณChina6.5%+25.0%31.5%
๐Ÿ‡ฒ๐Ÿ‡ฝMexico6.5%โ€”6.5%
๐Ÿ‡จ๐Ÿ‡ฆCanada6.5%โ€”6.5%
๐Ÿ‡ฉ๐Ÿ‡ชGermany6.5%โ€”6.5%
๐Ÿ‡ฏ๐Ÿ‡ตJapan6.5%โ€”6.5%

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

2933.39.61Lower: 6.5% vs 31.5%

If classified as a heterocyclic compound without drug-specific use

Beta-blockers like atenolol may fall under heterocyclic compounds in 2933 if not specifically designated as drugs.

3004.90Lower: 10% vs 31.5%

If when imported as finished tablets or capsules

Completed pharmaceutical products are classified in Chapter 30 based on end-use rather than chemical structure.

2941.90.10Lower: Free vs 31.5%

If for antibiotics with similar aromatic structure

Antibiotics are specifically covered in 2941, taking precedence over general aromatic drugs in 2942.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

โ€ข Verify drug status with FDA registration and provide Certificate of Analysis confirming aromatic structure

โ€ข Ensure compliance with DEA scheduling if applicable; avoid misclassification as Chapter 30 finished dosage forms

โ€ข Include stability data for transport as per Chapter 29 note (f) to prevent reclassification

Related Products under HTS 2942.00.05.00

Modified Aromatic Antihistamine Loratadine

Loratadine is a second-generation antihistamine with modified aromatic structure used for allergy relief. Classified under HTS 2942.00.05.00 as an aromatic drug not fitting other specific organic compound headings. Its piperidine ring modification qualifies it as 'modified aromatic'.

Aromatic Antiviral Acyclovir

Acyclovir is a synthetic guanosine analogue with aromatic components used against herpes viruses. It qualifies for HTS 2942.00.05.00 as an aromatic drug compound meeting Chapter 29 scope for separate chemically defined organics. Excluded from Chapter 30 as pure API.

Aromatic Calcium Channel Blocker Amlodipine

Amlodipine besylate is an aromatic dihydropyridine calcium channel blocker for hypertension treatment. Falls under 2942.00.05.00 as a modified aromatic drug API, distinguished from bulk medicinals in Chapter 30. Meets criteria for separate chemically defined organic compounds.

Modified Aromatic Proton Pump Inhibitor Omeprazole

Omeprazole is a benzimidazole derivative with modified aromatic structure used for acid reflux treatment. Classified in HTS 2942.00.05.00 as an aromatic drug API meeting Chapter 29 chemical definition. Excluded from dyes/colorants per Chapter exclusions.

Aromatic Antidepressant Sertraline Hydrochloride

Sertraline HCl is a selective serotonin reuptake inhibitor with aromatic ring structure for depression treatment. HTS 2942.00.05.00 applies to this chemically defined aromatic drug, following salt classification rules of Chapter Note 5(C).

Aromatic Antifungal Fluconazole

Fluconazole is a triazole antifungal with aromatic components used for systemic fungal infections. Falls under HTS 2942.00.05.00 as an aromatic drug, separate from specific heterocyclics or antibiotics. Pure API form excludes Chapter 30 classification.